Patients & Caregivers / Clinical Trials/Research Studies
Communication about Type 2 Diabetes Treatment in Older Adults with Memory Problems
Description: This study is investigating how diabetes treatment goals and medication decisions are made for older adults with both Type 2 Diabetes Mellitus (T2DM) and memory problems. We will be interviewing 12 informal (unpaid) caregivers of older adults with both T2DM and memory problems.
Study Length: Participation involves one telephone interview that takes 30-60 minutes. Participants will be compensated $40 for completing the interview.
You may be eligible if you:
EXPEDITION 3 Clinical Trial
Description: This study will test the idea that the investigational medication solanezumab will slow the cognitive and functional decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.
Study Length: Approximately 18 months
Carolyn Rickard at 412-692-2707 email@example.com or
MaryAnn Oakley at 412-692-2721 or firstname.lastname@example.org
Medication Study for the Treatment of Agitation in Moderate to Severe Alzheimer's Disease
Description: The purpose of this study is to determine whether an investigational medication (ELND005) is effective for reducing behaviors in people with moderate to severe Alzheimer's disease who have agitation/aggression.
Study Length: 12 Weeks
Objective Evaluation of Family Caregiving Study
Description: The goal of this study is to learn how family caregivers deal with dementia-related behavior and how they respond to suggestions for handling these situations at home. Participants will be asked to wear a video device at home to capture daily interactions with their family member with dementia.
Study Length: 3-4 months
|Epidemiology Data Center||© All Rights Reserved||University of Pittsburgh|